fashion -WSS

fashion

author：fashion 2025-09-28 18:20:39 - browse：1858

A person wears a headset projecting a brain -- health tech coverage from STAT — Adobe

Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the neurodegenerative disease.

With the new Series B extension funding, the Cambridge, Mass.-based company has now raised $128 million to develop its headset that uses gamma frequency light and sound stimulation to combat the cognitive decline that’s the hallmark of Alzheimer’s. Cognito is currently undertaking a large study of the treatment and CEO Brent Vaughan told STAT he expects the company to complete the trial and submit data to the Food and Drug Administration for review by the end of 2025.

While under treatment, patients use the device for one hour per day in their homes. The light and sound is supposed to stimulate brain activity that’s disrupted by neurodegenerative conditions, potentially helping to preserve brain structure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

WSS

STAT wants to know your pick for a great summer read or listen

How CO2 helps viruses stay alive longer in the air

Ending racial health disparities hinges on penalties, political will

Tocagen's brain cancer gene therapy trial continues. Investors worry

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

leisure time

fashion

leisure time

Cancer drug shortages should be causing more outrage

ASCO Takeaways: Winners, snoozers, and the art of cancer care

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Data don't support strong claims for Covid

The cancer drug shortage isn’t new — and neither are the solutions

An outdated Medicare rule harms dementia patients with anxiety

Anesthesiologist group: stop taking Ozempic before surgery

Elevance PBM president out as customers face prescription chaos

Wildfire smoke exposes gaps in outdoor worker protections

ASCO Takeaways: Winners, snoozers, and the art of cancer care

entertainment

The most pressing bird flu mysteries scientists want answered

BD to buy Edwards patient monitoring unit for $4.2 billion

Ending racial health disparities hinges on penalties, political will

Finland to offer bird flu vaccine to select groups of people, a possible global first

Tesla recalling nearly 16,000 of its 2021

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

explore

entertainment

focus

knowledge